Newsletter Archive

  1. 11.14.25 -- Overcoming Roadblocks To Advanced Therapy Manufacture 11/14/2025

    11/14/25 Bioprocess Online Newsletter

  2. 11.14.25 -- STREAM Edition: Navigating The Complexity Of Conditionally Active Biologics 11/14/2025
    11/14/25 Bioprocess Online Newsletter
  3. 11.14.25 -- Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms 11/14/2025
    11/14/25 Bioprocess Online Newsletter
  4. 11.13.25 -- Solutions To Achieve Your Next AAV Gene Therapy Milestone With Confidence In Every Batch 11/13/2025

    11/13/25 Bioprocess Online Newsletter

  5. 11.13.25 -- Take Strides Not Steps With Your Cell & Gene Therapy Manufacturing Process 11/13/2025

    11/13/25 Bioprocess Online Newsletter

  6. 11.13.25 -- AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing 11/13/2025
    11/13/25 Bioprocess Online Newsletter
  7. 11.12.25 -- Scaling Smarter In Biologics Manufacturing 11/12/2025

    11/12/25 Bioprocess Online Newsletter

  8. 11.12.25 -- Oligo Scale-Up Just Got Easier – Here's How 11/12/2025
    11/12/25 Bioprocess Online Newsletter
  9. 11.12.25 -- The Transition To E-Labeling Is More Than Uploading PDFs 11/12/2025
    11/12/25 Bioprocess Online Newsletter
  10. 11.11.25 -- DNA-To-IND In Record Time? The Blueprint For Accelerating Biologics 11/11/2025

    11/11/25 Bioprocess Online Newsletter